Open | - |
Close | - |
Volume / Avg. | 2.173K / 752.033K |
Day Range | - - - |
52 Wk Range | 15.230 - 47.580 |
Market Cap | $3.312B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 6.35% |
Days to Cover | 6.34 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Crinetics Pharmaceuticals (NASDAQ: CRNX) through any online brokerage.
Other companies in Crinetics Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX), SpringWorks Therapeutics (NASDAQ:SWTX) and TG Therapeutics (NASDAQ:TGTX).
The latest price target for Crinetics Pharmaceuticals (NASDAQ: CRNX) was reported by Oppenheimer on Wednesday, March 13, 2024. The analyst firm set a price target for 54.00 expecting CRNX to rise to within 12 months (a possible 27.06% upside). 33 analyst firms have reported ratings in the last year.
The stock price for Crinetics Pharmaceuticals (NASDAQ: CRNX) is $42.5 last updated Today at March 19, 2024 at 6:36 AM EDT.
There are no upcoming dividends for Crinetics Pharmaceuticals.
Crinetics Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Crinetics Pharmaceuticals.
Crinetics Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.